Discovery of Small Molecule Inhibitors of PCSK9 Using Virtual Screening as Potential Therapeutics for Atherosclerosis
<p style="margin-left:0cm; margin-right:0cm">High LDL cholesterol can cause heart disease. Current treatments like statins are not always effective, so new therapies are needed. PCSK9 is a protein that reduces the number of LDL receptors in the liver, which keeps cholesterol in the blood, making it a strong target for
Authors
- Matthew N. Siciliano
Publication Details
- Journal
- European Journal of Biomedical and Life Sciences
- Published
- 2026-03-31
- DOI
- https://doi.org/10.29013/ejbls-26-1-15-32
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00